Rafferty Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-60,887
| Closed | -$3.55M | – | 1117 |
|
|
2023
Q1 | $3.55M | Buy |
60,887
+14,443
| +31% | +$843K | 0.02% | 470 |
|
|
2022
Q4 | $2.37M | Buy |
46,444
+1,910
| +4% | +$97.4K | 0.02% | 531 |
|
|
2022
Q3 | $3.65M | Buy |
44,534
+13,907
| +45% | +$1.14M | 0.04% | 384 |
|
|
2022
Q2 | $2.07M | Sell |
30,627
-23,302
| -43% | -$1.58M | 0.02% | 453 |
|
|
2022
Q1 | $5.96M | Buy |
53,929
+28,558
| +113% | +$3.16M | 0.04% | 332 |
|
|
2021
Q4 | $2.45M | Buy |
25,371
+639
| +3% | +$61.6K | 0.01% | 590 |
|
|
2021
Q3 | $2.16M | Buy |
24,732
+7,881
| +47% | +$688K | 0.01% | 622 |
|
|
2021
Q2 | $2.61M | Sell |
16,851
-1,193
| -7% | -$185K | 0.02% | 576 |
|
|
2021
Q1 | $2.85M | Buy |
18,044
+14,115
| +359% | +$2.23M | 0.02% | 524 |
|
|
2020
Q4 | $912K | Sell |
3,929
-5,386
| -58% | -$1.25M | 0.01% | 530 |
|
|
2020
Q3 | $2.04M | Buy |
9,315
+5,503
| +144% | +$1.21M | 0.02% | 410 |
|
|
2020
Q2 | $1.08M | Buy |
3,812
+2,984
| +360% | +$848K | 0.02% | 521 |
|
|
2020
Q1 | $239K | Sell |
828
-6,216
| -88% | -$1.79M | 0.01% | 485 |
|
|
2019
Q4 | $2.03M | Sell |
7,044
-6,063
| -46% | -$1.74M | 0.03% | 388 |
|
|
2019
Q3 | $1.89M | Buy |
+13,107
| New | +$1.89M | 0.03% | 403 |
|